| Dallas D Peck, MD | |
|
1055 N Curtis Rd, Boise, ID 83706-1309 | |
| (208) 367-2161 | |
| Not Available |
| Full Name | Dallas D Peck |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 1055 N Curtis Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184665473 | NPI | - | NPPES |
| 806032500 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | M8235 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crouse Hospital | Syracuse, NY | Hospital |
| Sky Lakes Medical Center | Klamath falls, OR | Hospital |
| Mercy Medical Center | Roseburg, OR | Hospital |
| Highland Hospital | Oakland, CA | Hospital |
| Christus Mother Frances Hospital | Tyler, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crouse Radiology Associates Llp | 1850387648 | 99 |
| Geisinger Clinic | 5395657001 | 2866 |
| Roseburg Radiologists Pc | 0446246003 | 37 |
| Virtual Radiologic Professionals Llc | 4981608817 | 355 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Entity Name | Gem State Radiology Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083661508 PECOS PAC ID: 9335044833 Enrollment ID: O20031205000623 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Entity Name | Intermountain Medical Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423679 PECOS PAC ID: 7517870918 Enrollment ID: O20090130000423 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Entity Name | Virtual Radiologic Professionals Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932342029 PECOS PAC ID: 4981608817 Enrollment ID: O20110429000544 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558313023 PECOS PAC ID: 5395657001 Enrollment ID: O20210907001560 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Entity Name | Roseburg Radiologists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700876117 PECOS PAC ID: 0446246003 Enrollment ID: O20220627001715 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952076119 PECOS PAC ID: 1355676370 Enrollment ID: O20230830000892 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Entity Name | Crouse Radiology Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447244587 PECOS PAC ID: 1850387648 Enrollment ID: O20230915002239 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dallas D Peck, MD Po Box 9649, Boise, ID 83707-4649 Ph: (208) 472-8100 | Dallas D Peck, MD 1055 N Curtis Rd, Boise, ID 83706-1309 Ph: (208) 367-2161 |
News Archive
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.
The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.
Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.
› Verified 5 days ago
Jeffrey T Seabourn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2161 | |
Caroline D Sobota, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2161 | |
Dr. Chad Eric Sarver, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Mr. Jesse W Spinner, MD Radiology Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2121 Fax: 706-596-6720 | |
Brian Lane Mcmahan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2094 Fax: 208-381-1791 | |
Craig E Leymaster, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2094 | |
John A Jackson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2161 |